Pfm Health Sciences, LP Adaptimmune Therapeutics PLC Transaction History

Pfm Health Sciences, LP

  • $1.71 Billion
  • Q3 2024

A detailed history of Pfm Health Sciences, LP transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Pfm Health Sciences, LP holds 10,000,787 shares of ADAP stock, worth $6.6 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
10,000,787
Previous 10,520,231 4.94%
Holding current value
$6.6 Million
Previous $10.3 Million 7.85%
% of portfolio
0.56%
Previous 0.53%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.92 - $1.39 $477,888 - $722,027
-519,444 Reduced 4.94%
10,000,787 $9.5 Million
Q2 2024

Aug 14, 2024
BUY
$0.83 - $1.47 $80,589 - $142,731
97,096 Added 0.93%
10,520,231 $10.3 Million
Q3 2023

Nov 14, 2023
BUY
$0.73 - $1.04 $1.51 Million - $2.15 Million
2,065,893 Added 24.72%
10,423,135 $8.13 Million
Q2 2023

Aug 14, 2023
BUY
$0.9 - $1.51 $2.13 Million - $3.57 Million
2,364,671 Added 39.46%
8,357,242 $7.69 Million
Q1 2023

May 15, 2023
BUY
$1.06 - $2.16 $1.22 Million - $2.48 Million
1,149,061 Added 23.72%
5,992,571 $6.53 Million
Q4 2022

Feb 14, 2023
SELL
$1.05 - $2.53 $4.7 Million - $11.3 Million
-4,477,074 Reduced 48.03%
4,843,510 $7.07 Million
Q3 2022

Nov 14, 2022
BUY
$1.06 - $2.41 $223,452 - $508,037
210,804 Added 2.31%
9,320,584 $10 Million
Q2 2022

Aug 15, 2022
BUY
$1.33 - $2.28 $8.96 Million - $15.4 Million
6,735,106 Added 283.62%
9,109,780 $15.5 Million
Q1 2022

May 16, 2022
SELL
$1.73 - $4.06 $1.43 Million - $3.36 Million
-826,392 Reduced 25.82%
2,374,674 $4.89 Million
Q4 2021

Feb 14, 2022
SELL
$3.5 - $5.68 $4.21 Million - $6.83 Million
-1,202,508 Reduced 27.31%
3,201,066 $12 Million
Q3 2021

Nov 15, 2021
BUY
$3.44 - $6.37 $2.67 Million - $4.94 Million
775,674 Added 21.38%
4,403,574 $22.8 Million
Q2 2021

Aug 16, 2021
BUY
$3.86 - $5.78 $4.35 Million - $6.51 Million
1,126,597 Added 45.04%
3,627,900 $15.5 Million
Q1 2021

May 17, 2021
SELL
$4.9 - $6.83 $947,983 - $1.32 Million
-193,466 Reduced 7.18%
2,501,303 $13.3 Million
Q4 2020

Feb 16, 2021
BUY
$4.0 - $9.2 $7.38 Million - $17 Million
1,845,329 Added 217.24%
2,694,769 $14.5 Million
Q3 2020

Nov 16, 2020
BUY
$7.66 - $10.78 $6.51 Million - $9.16 Million
849,440 New
849,440 $6.78 Million

Others Institutions Holding ADAP

# of Institutions
82
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $108M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email